Ariad Pharmaceuticals Inc (NASDAQ:ARIA)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

0
Player Avatar pchop123 (79.61) Submitted: 4/8/2013 10:12:01 AM : Outperform Start Price: $16.85 ARIA Score: +5.26

getting oversold

Featured Broker Partners


Advertisement